1. Signaling Pathways
  2. Anti-infection
  3. Parasite
  4. Amebae Isoform

Amebae

The free-living amebae (FLA) are found in both the natural environment and in man-made facilities and may occasionally be human parasites. While many FLA have been identified, the three main genera associated with human disease are Acanthamoeba spp., Balamuthia mandrillaris and Naegleria fowleri. Infection with N. fowleri is exceedingly rare and is not common in immunocompromised hosts. Both Acanthamoeba species and B. mandrillaris cause granulomatous amebic encephalitis (GAE), primarily in immunocompromised hosts, while Acanthamoeba spp. can also cause a localized infection of the eye, referred to as amebic keratitis (AK).

The life cycle of both FLAs involves two forms: an actively dividing trophozoite stage and a dormant cyst stage. Trophozoites are uninucleate, divide through binary fission, and feed on surrounding bacteria and algae through phagocytosis or pseudopod formation. If environmental conditions become challenging (e.g., desiccation, osmolarity imbalance, nutrient deprivation, etc.), trophozoites will encyst and become resistant to most antimicrobials and biocides. Cysts remain viable for years and will yield pathogenic trophozoites. Of note, the virulence of excysted trophozoites decreases with duration of encystment. While the trophozoite stage is the infectious form, infection can also be acquired through contact with cysts which will subsequently excyst under amenable conditions. Exposure to both organisms is thought to be due to inhalation of the organism into the lower respiratory tract and/or contamination of broken skin.

Amebae Related Products (16):

Cat. No. Product Name Effect Purity
  • HY-B0956
    Paromomycin sulfate
    Inhibitor 99.91%
    Paromomycin (Aminosidine) sulfate, a neomycin (HY-B0470) derivative, is a broad spectrum aminoglycoside antibiotic with amebicidal and bactericidal effects. Paromomycin sulfate prematures termination of translation of mRNA and inhibits protein synthesis by specifically binds to the RNA oligonucleotide at the A site of bacterial 30S ribosomes. Paromomycin sulfate can be used for the research of bacterial and parasitic infections.
  • HY-B0751
    Fumagillin
    Inhibitor ≥99.0%
    Fumagillin(NSC9168) is an antimicrobial compound first isolated in 1949 from the fungus Aspergillus fumigatu. Fumagillin can inhibits HIV‐1 infection through the inhibition of HIV-1 viral protein R (Vpr) activity.
  • HY-B0295
    Chloroxine
    Inhibitor 99.79%
    Chloroxine is one of the important 8-hydroxyquinoline derivative. Chloroxine has effective antibacterial, antifungal, antiprotozoal and antiamoebic activities, especially used in treating the intestinal amebiasis. Chloroxine is also used in the treatment of dandruff and seborrheic dermatitis of the scalp.
  • HY-B0963
    Cloxiquine
    Inhibitor 99.66%
    Cloxiquine (5-Chloro-8-quinolinol) is an antibacterial, antifungal and antiamoebic agent. Cloxiquine can be used for the research of tuberculosis and dermatoses. Cloxiquine suppresses the growth and metastasis of melanoma cells through activation of PPARγ.
  • HY-B1118
    Secnidazole
    Inhibitor 99.87%
    Secnidazole (RP-14539) is an orally active azole antibiotic and a imidazole mitigator of Serratia marcescens virulence. Secnidazole, as an analog of acylhomoserine lactones, effectively inhibits QS resulting in the attenuation of Pseudomonas aeruginosa pathogenesis. Secnidazole has antimicrobial activity against many anaerobic Gram-negative and Gram-positive bacterial species in vitro. Secnidazole can be used for the research of various diseases, such as amoebiasis and giardiasis, and bacterial vaginitis.
  • HY-15537
    Tilbroquinol
    Inhibitor 98.02%
    Tilbroquinol is an orally active antiparasite agent, can be used in study of amoebiasis. tilbroquinol is also used against Vibrio cholera.
  • HY-119972
    Diloxanide
    Inhibitor 99.71%
    Diloxanide is an anti-protozoal agent and can be used for the research of asymptomatic-intestinal amebiasis caused by Entamoeba histolytica or some other protozoal infections. Diloxanide is an active luminal amebicide and hydrolyzed in the gastrointestinal tract from its proagent Diloxanide furoate (HY-B1147).
  • HY-B1147
    Diloxanide furoate
    Inhibitor 99.80%
    Diloxanide furoate is the proagent of Diloxanide. Diloxanide furoate is a potent and orally active anti-protozoal agent and can be used for the research of amebiasis, mild intestinal amebiasis or asymptomatic cyst carriers.
  • HY-115249
    Metronidazole acetic acid
    Inhibitor 98.18%
    Metronidazole acetic acid is a metabolite of Metronidazole with mutagenic activity in bacteria. Metronidazole is a nitroimidazole antibiotic, amebicide, and antiprotozoal agent used particularly for anaerobic bacteria and protozoa.
  • HY-101715
    Panidazole
    Inhibitor 98.77%
    Panidazole is an amoebicide.
  • HY-B1118A
    Secnidazole hemihydrate
    Inhibitor
    Secnidazole (RP-14539) hemihydrate is an orally active azole antibiotic and a imidazole mitigator of Serratia marcescens virulence. Secnidazole hemihydrate, as an analog of acylhomoserine lactones, effectively inhibits QS resulting in the attenuation of Pseudomonas aeruginosa pathogenesis. Secnidazole hemihydrate has antimicrobial activity against many anaerobic Gram-negative and Gram-positive bacterial species in vitro. Secnidazole hemihydrate can be used for the research of various diseases, such as amoebiasis and giardiasis, and bacterial vaginitis.
  • HY-B1118S
    Secnidazole-d6
    Inhibitor
    Secnidazole-d6 is the deuterium labeled Secnidazole. Secnidazole (RP-14539;PM-185184) is an orally active azole antibiotic with a longer half-life than metronidazole (HY-B0318). Secnidazole is against the vaginosis-associated bacteria and has the potential for bacterial vaginosis research[1].
  • HY-119826
    Quinfamide
    99.69%
    Quinfamide is an antiamebic agent. Quinfamide has the potential to treat tropical parasitic infections such as Amoebiasis and Helminthiasis.
  • HY-B1118S1
    Secnidazole-13C2, 15N2
    Inhibitor
    Secnidazole-13C2, 15N2 is the 13C2, 15N2 labeled Secnidazole. Secnidazole (RP-14539;PM-185184) is an orally active azole antibiotic with a longer half-life than metronidazole (HY-B0318). Secnidazole is against the vaginosis-associated bacteria and has the potential for bacterial vaginosis research.
  • HY-N10471
    F3226-1387
    Inhibitor
    F3226-1387 is a potent Entamoeba histolytica O-acetylserine sulfhydrylase EhOASS3 inhibitor with an IC50 value of 38 μM. F3226-1387 can suppress the growth of the amoeba.
  • HY-126406
    Tirandamycin A
    Inhibitor
    Tirandamycin A, an antibiotic, is a bacterial RNA polymerase inhibitor. Tirandamycin A has antiamoebic and antibacterial properties.